We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biomarker Panel Predicts Severity of Pollen Allergy Symptoms

By LabMedica International staff writers
Posted on 12 May 2020
Print article
Image: Scanning electron microscope image (500x magnification) of pollen grains from a variety of common plants (Photo courtesy of Dartmouth Electron Microscope Facility, Dartmouth College (via Wikimedia Commons)
Image: Scanning electron microscope image (500x magnification) of pollen grains from a variety of common plants (Photo courtesy of Dartmouth Electron Microscope Facility, Dartmouth College (via Wikimedia Commons)
A team of German researchers has identified a panel of biomarkers that predicts the severity of allergic symptoms even before the start of the pollen season.

In addition to physical symptoms such as sneezing, rhinitis, and watery eyes pollen exposure induces local and systemic allergic immune responses in sensitized individuals. The kinetics of symptom expression under natural pollen exposure have never been systematically studied, especially in subjects without allergy.

To rectify this situation, investigators at the Helmholtz Zentrum München - German Research Center for Environmental Health (Munich, Germany) compared humoral immune response kinetics in a panel study of subjects with seasonal allergic rhinitis (SAR) and subjects without allergy.

Subjects were monitored over a period of one year. In addition to a digital symptom diary kept daily by the study participants, the investigators analyzed samples of blood and nasal secretions. They then compared immune variables (cytokines, chemokines, and pollen-specific immunoglobulins) in samples obtained during and after the pollen season.

Results revealed that allergic symptoms appeared following exposure to concentrations of airborne pollen in subjects with SAR with a time lag between 0 and 13 days depending on the pollen type. Of the seven nonallergic subjects four also exhibited in-season symptoms whereas three did not. Cumulative symptoms in those without allergy were lower than in those with SAR but followed pollen exposure with similar kinetics. Principal component analysis and Spearman correlations identified nasal levels of IL-8, IL-33, and Betula verrucosa 1-specific IgG4 (sIgG4) and Betula verrucosa 1-specific IgE antibodies as predictive for seasonal symptom severity.

First author Mehmet Gökkaya, a researcher at the Helmholtz Zentrum München - German Research Center for Environmental Health, said, "The identification of biomarkers helps us in three ways. Firstly, by predicting the severity of nasal symptoms we can better identify the patients who benefit the most from therapeutic treatment. Secondly, biomarkers can help us understand the processes at work during the development of allergies in non-allergic patients and so help us to be ultimately able to prevent them. And thirdly, biomarkers can be used to identify the physiological processes that originally cause these symptoms. Possibly this could be a new starting point for the development of novel therapeutics."

The study was published in the April 6, 2020, online edition of the Journal of Allergy and Clinical Immunology.

Related Links:
Helmholtz Zentrum München - German Research Center for Environmental Health

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.